Data / Form D filings / PanOptica, Inc.
PanOptica, Inc.: Form D filings
PanOptica, Inc., a biotechnology company in Mt. Arlington, NJ, filed 6 Form D notices with the SEC between 2010 and 2019. The latest, on April 10, 2019, reports $40.7 million sold of a $47.3 million offering to 6 investors.
Find out what PanOptica, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13 MCGREGOR AVENUE, Mt. Arlington, NJ, 07856
- Phone
- 1-732-539-9859
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Massachusetts
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1508856
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2019 | Amendment | $47,281,615 | $40,681,615 | $6,600,000 | 6 | Apr 10, 2014 | sec.gov |
| Oct 16, 2017 | Amendment | $47,281,615 | $30,208,616 | $17,072,999 | 6 | Apr 10, 2014 | sec.gov |
| May 27, 2016 | Amendment | $27,131,616 | $23,883,195 | $3,248,421 | 5 | Apr 10, 2014 | sec.gov |
| Apr 17, 2014 | New notice | $45,465,696 | $12,625,699 | $32,839,997 | 5 | Apr 10, 2014 | sec.gov |
| Mar 6, 2012 | Amendment | $36,147,034 | $16,580,368 | $19,566,666 | 5 | Dec 10, 2010 | sec.gov |
| Dec 27, 2010 | New notice | $30,000,000 | $10,533,333 | $19,466,667 | 5 | Dec 10, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Abbie Celniker | Director | |
| David Guyer | Director | |
| Paul Chaney | Executive Officer, Director | |
| Bruce Peacock | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Apr 8, 2019 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PanOptica, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.